US 11083720
Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases
granted A61KA61K31/416A61K31/4439
Quick answer
US patent 11083720 (Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/416, A61K31/4439, A61K31/496, A61K31/506